The Effect of Injectable Platelet-rich Fibrin on Alveolar Bone Defects

Yıl 2019, Cilt: 3 Sayı: 1, 1 - 2, 13.10.2019

Gözde Işık Tayfun Günbay Semiha Özgül

Öz

Introduction: The aim of this study was to assess the theory of whether injectable platelet-rich fibrin (i-PRF) mixed particulate graft material provides adequate treatment outcomes without barrier membranes, in patients who have insufficient alveolar bone width on dental implant treatment. Materials and Methods: This case-control study was conducted in patients who have alveolar bone width (ABW) of less than 4 mm in the anterior maxilla. Patients who treated with simultaneously dental implant surgery were divided into 3 groups: collagen membrane + i-PRF mixed particulate allogeneic graft (PAG) in group I (mean age 38.64±4.45 years), leukocyte and platelet-rich fibrin (L-PRF) + i-PRF mixed PAG in group II (mean age 36.57±5.19 years), and i-PRF mixed PAG in group III (mean age 36.21±6.85 years). Cone-beam computed tomography were obtained before the surgery and at 6 months postoperatively. The repeated measure ANOVA was carried out to assess the change of ABW between the groups by using the SPSS program with a significance level of α = 0.05. Results: The initial ABW in the study groups was observed 3.09±0.45, 3.15±0.39 and 3.06±0.66, respectively (ANOVA result: p=0.891) and there were no statistically significant differences between the groups. The change of ABW in group III (7.04±0.62) was found to be higher compared to group I (6.62±0.52) and group II (6.68±0.50) (Dunnett T3 results: p=0.026 and p=0.009, respectively). Discussion & Conclusion: Based on the results of this study, i-PRF can be considered as an alternative method in particulate bone grafts to provide treatment of localized alveolar bone defects. Keywords: Injectable platelet-rich fibrin; localized alveolar bone defects; alveolar bone augmentation. Keywords: Injectable platelet-rich fibrin, localized alveolar bone defects, alveolar bone augmentation.

Anahtar Kelimeler

localized alveolar bone defects, alveolar bone augmentation, Injectable platelet-rich fibrin

Kaynakça

• .